Patents by Inventor Eamonn Connolly

Eamonn Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20050129629
    Abstract: Strains of Lactobacillus that have been selected for their capability of reducing the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with good binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: January 21, 2005
    Publication date: June 16, 2005
    Inventors: Bo Mollstam, Eamonn Connolly
  • Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
    Patent number: 6872565
    Abstract: Strains of Lactobacillus that have been selected for their capability of reducing the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with good binding to the oral mucins and dental plaque, Administering the strains in a product such as food, reduces and treats dental caries. Preferred strains are Lactobacillus reuteri strain ATTC PTA-4965 or Lactobacillus reuteri strain ATTC PTA-4964.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: March 29, 2005
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20050002874
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: June 14, 2004
    Publication date: January 6, 2005
    Inventors: Bo Mollstam, Eamonn Connolly
  • Anti-inflammatory activity from lactic acid bacteria
    Publication number: 20040208863
    Abstract: In the present invention, lactic acid bacteria produce soluble factors (such as peptides or proteins) that block inflammatory responses in a mechanism that depends on G proteins and is post-transcriptional to effectively block protein production or secretion by cells.
    Type: Application
    Filed: January 29, 2004
    Publication date: October 21, 2004
    Inventors: James Versalovic, Jeremy A. Pena, Eamonn Connolly
  • Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20040146493
    Abstract: Strains of Lactobacillus that have been selected for their capability of reducing the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with good binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: January 29, 2003
    Publication date: July 29, 2004
    Inventors: Bo Mollstam, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammmation caused by helicobacter
    Publication number: 20040067573
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: October 7, 2002
    Publication date: April 8, 2004
    Inventors: Eamonn Connolly, Bo Mollstam